The findings of a pilot program for the D3 imaging system were recently shared in the Proceedings of the National Academy of Sciences.
D3 is short for digital diffraction diagnosis, which is an imaging module with a high powered LED light, which clips on to a smartphone. The end result is a high resolution imaging device that has a field of view superior to that of a traditional microscope.
As confirmed by IndustryWeek, the system has the ability to record data from over 100,000 cells from blood, biopsy, or a tissue sample. Microbeads are added to the blood or tissue, which is then combined to detect cancer related molecules. Analyzing the diffraction patterns helps to determine if cancer is present.
The benefits of this technology are many. The average price is currently $1.80 per patient, and eliminates patient related stress caused by waiting several days because results are delivered within minutes.
Best of all, we’re told that the pilot tests for both irregular pap smears and lymphoma provided the same level of accuracy as traditional diagnostic testing.